scholarly article | Q13442814 |
P50 | author | Wenjing Zhang | Q85398556 |
P2093 | author name string | Wei Deng | |
John A Sweeney | |||
Fei Li | |||
Qiyong Gong | |||
Li Yao | |||
Su Lui | |||
Yuan Xiao | |||
Jieke Liu | |||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | schizophrenia | Q41112 |
P304 | page(s) | 995-1003 | |
P577 | publication date | 2015-06-18 | |
P1433 | published in | American Journal of Psychiatry | Q1935368 |
P1476 | title | Brain Structural Abnormalities in a Group of Never-Medicated Patients With Long-Term Schizophrenia | |
P478 | volume | 172 |
Q47686000 | A diffusion weighted imaging study of basal ganglia in schizophrenia. |
Q37612065 | Alterations in Cortical Thickness and White Matter Integrity in Mild-to-Moderate Communicating Hydrocephalic School-Aged Children Measured by Whole-Brain Cortical Thickness Mapping and DTI. |
Q48007135 | An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers |
Q64298943 | Association of a Schizophrenia-Risk Nonsynonymous Variant With Putamen Volume in Adolescents: A Voxelwise and Genome-Wide Association Study |
Q47386048 | Brain Structure Biomarkers in the Psychosis Biotypes: Findings From the Bipolar-Schizophrenia Network for Intermediate Phenotypes |
Q94600188 | Characteristics of gray matter alterations in never-treated and treated chronic schizophrenia patients |
Q38872560 | Combination of volume and perfusion parameters reveals different types of grey matter changes in schizophrenia |
Q48460836 | Common pattern of gray-matter abnormalities in drug-naive and medicated first-episode schizophrenia: a multimodal meta-analysis. |
Q53266198 | Deviation from expected cognitive ability across psychotic disorders. |
Q41580027 | Differential Cortical Gray Matter Deficits in Adolescent- and Adult-Onset First-Episode Treatment-Naïve Patients with Schizophrenia |
Q92518217 | Functional brain networks in never-treated and treated long-term Ill schizophrenia patients |
Q41041009 | Gray Matter Abnormalities in Non-comorbid Medication-naive Patients with Major Depressive Disorder or Social Anxiety Disorder |
Q90871787 | Gray matter bases of psychotic features in adult bipolar disorder: A systematic review and voxel-based meta-analysis of neuroimaging studies |
Q52091530 | Is There an Association Between Mismatch Negativity and Cortical Thickness in Schizophrenia Patients? |
Q36740180 | Medial Prefrontal and Anterior Insular Connectivity in Early Schizophrenia and Major Depressive Disorder: A Resting Functional MRI Evaluation of Large-Scale Brain Network Models |
Q55341458 | Multilocus genetic profile in dopaminergic pathway modulates the striatum and working memory. |
Q31137558 | Psychoradiology: The Frontier of Neuroimaging in Psychiatry. |
Q59135280 | Structural and functional brain abnormalities in drug-naive, first-episode, and chronic patients with schizophrenia: a multimodal MRI study |
Q38812229 | Structural neuroimaging across early-stage psychosis: Aberrations in neurobiological trajectories and implications for the staging model. |
Q41535826 | The neurobiology of transition to psychosis: clearing the cache. |
Q39002140 | The treatment of schizophrenia: Can we raise the standard of care? |
Q89901286 | Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning |
Q55023835 | What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia? |
Search more.